Cytokine Release Syndrome: Symptoms, Causes, Treatment

Cytokines are immune signals; excessive release can disrupt circulation and breathing. Fever after treatment is not automatically CRS, because infection can mimic or accompany it.

Related reading: Tumor lysis as a different cancer-treatment emergency.

Fever, chills, fatigue, aches and nausea may precede low blood pressure, rapid pulse or low oxygen. Speech or awareness changes can indicate associated neurological toxicity.

Therapy can activate immune cells to release large quantities of inflammatory signals. Timing and risk vary by treatment, dose and disease burden; one time window does not fit everyone.

Treatment type, tumor burden, health status, infection and inflammatory factors influence risk. Age or a single symptom cannot determine individual risk without the treating team.

Assessment reviews treatment timing, temperature, blood pressure, oxygen and organ function while investigating infection and other causes. Severity reflects clinical support needs rather than one cytokine test.

Management follows the specific product and severity and may include monitoring, fluids, oxygen, tocilizumab or corticosteroids. Intensive care may be needed; suspected infection is treated concurrently.

Severe hypotension, respiratory failure or organ injury may occur, sometimes with neurotoxicity. Early recognition matters; CRS alone does not mean cancer treatment has failed.

Follow monitoring requirements and keep treatment information and contact numbers available. Do not use steroids or fever remedies to hide symptoms and delay calling; no home prevention is guaranteed.